PARP and PARG Inhibitors-New Therapeutic Targets in Cancer Treatment

被引：42

作者：

Fauzee, Nilufer Jasmine Selimah ^{[1
]}

Pan, Juan ^{[1
]}

Wang, Ya-lan ^{[1
]}

机构：

[1] Chongqing Med Univ, Dept Pathol, Mol Med & Canc Res Ctr, Chongqing 400016, Peoples R China

来源：

PATHOLOGY & ONCOLOGY RESEARCH | 2010年 / 16卷 / 04期

关键词：

PARP; PARG; PARP inhibitors; PARG inhibitors; ADP-RIBOSE POLYMERASE; POLY(ADP-RIBOSE) POLYMERASE; CELL-DEATH; DNA-DAMAGE; GLYCOHYDROLASE INHIBITOR; HOMOLOGOUS RECOMBINATION; BREAST-CANCER; TUMOR-GROWTH; SENSITIVITY; REPAIR;

D O I：

10.1007/s12253-010-9266-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Today, the number of cancer patients throughout the world is increasing alarmingly and as per the World Health Organisation (WHO) data and statistics the prediction for the year 2020 will be 15 million new cases as compared to only 10 million cases in year 2000 leaving us dumbfounded. A lot of effort has been put in by researchers and scientists over decades to find drugs helpful in the treatment of cancers for the benefit of patients-The latest being the Poly ADP-ribose polymerase (PARP) and the Poly ADP-ribose glycohydrolase (PARG) inhibitors. This review highlights their mechanism of action under the rationale of their use and current development in the field of cancer.

引用

页码：469 / 478

页数：10

共 107 条

[41] Transcriptional coactivation of nuclear factor-κB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1 [J].

Hassa, PO ;

Buerki, C ;

Lombardi, C ;

Imhof, R ;

Hottiger, MO .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (46) :45145-45153

[42]

HIRAI K, 1983, CANCER RES, V43, P3441

[43] Parp-1 protects homologous recombination from interference by Ku and ligase IV in vertebrate cells [J].

Hochegger, H ;

Dejsuphong, D ;

Fukushima, T ;

Morrison, C ;

Sonoda, E ;

Schreiber, V ;

Zhao, GY ;

Saberi, A ;

Masutani, M ;

Adachi, N ;

Koyama, H ;

de Murcia, G ;

Takeda, S .

EMBO JOURNAL, 2006, 25 (06) :1305-1314

[44] RETRACTED: A novel function of poly(ADP-ribose) polymerase-1 in modulation of autophagy and necrosis under oxidative stress (Retracted article. See vol. 17, pg. 1944, 2010) [J].

Huang, Q. ;

Wu, Y-T ;

Tan, H-L ;

Ong, C-N ;

Shen, H-M .

CELL DEATH AND DIFFERENTIATION, 2009, 16 (02) :264-277

[45] Poly(ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/β-catenin complex [J].

Idogawa, M ;

Yamada, T ;

Honda, K ;

Sato, S ;

Imai, K ;

Hirohashi, S .

GASTROENTEROLOGY, 2005, 128 (07) :1919-1936

[46] MNNG-induced cell death is controlled by interactions between PARP-1, poly(ADP-ribose) glycohydrolase, and XRCC1 [J].

Keil, Claudia ;

Groebe, Tina ;

Oei, Shiao Li .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (45) :34394-34405

[47] Preclinical Modeling of a Phase 0 Clinical Trial: Qualification of a Pharmacodynamic Assay of Poly (ADP-Ribose) Polymerase in Tumor Biopsies of Mouse Xenografts [J].

Kinders, Robert J. ;

Hollingshead, Melinda ;

Khin, Sonny ;

Rubinstein, Larry ;

Tomaszewski, Joseph E. ;

Doroshow, James H. ;

Parchment, Ralph E. .

CLINICAL CANCER RESEARCH, 2008, 14 (21) :6877-6885

[48] Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function [J].

Klaidman, L ;

Morales, M ;

Kem, S ;

Yang, J ;

Chang, ML ;

Adams, JD .

PHARMACOLOGY, 2003, 69 (03) :150-157

[49] Mediation of cell death by poly(ADP-ribose) polymerase-1 [J].

Koh, DW ;

Dawson, TM ;

Dawson, VL .

PHARMACOLOGICAL RESEARCH, 2005, 52 (01) :5-14

[50] Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality [J].

Koh, DW ;

Lawler, AM ;

Poitras, MF ;

Sasaki, M ;

Wattler, S ;

Nehls, MC ;

Stöger, T ;

Poirier, GG ;

Dawson, VL ;

Dawson, TM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (51) :17699-17704

← 1 2 3 4 5 6 7 8 9 10 →